A phase II study of sirolimus, tacrolimus, and rabbit anti-thymocyte globulin as graft-versus-host prophylaxis after unrelated-donor peripheral blood stem cell transplant

por Khaled, Samer K., Palmer, Joycelynne, StillerMS, Tracey, Senitzer, David, Maegawa, Rodrigo, Rodriguez, Roberto, Parker, Pablo M., Nademanee, Auayporn, Cai, Ji-Lian, Snyder, David S., Karanes, Chatchada, Osorio, Edna, Thomas, Sandra H., Forman, Stephen J., Nakamura, Ryotaro
Publicado 2012